NU.V - NeutriSci International Inc.

TSXV - TSXV Delayed Price. Currency in CAD
0.095
-0.005 (-5.00%)
At close: 3:12PM EDT
Stock chart is not supported by your current browser
Previous Close0.100
Open0.100
Bid0.095 x 0
Ask0.100 x 0
Day's Range0.095 - 0.100
52 Week Range0.060 - 0.350
Volume153,600
Avg. Volume293,182
Market Cap9.505M
Beta4.63
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
All
News
Press Releases
  • GlobeNewswirelast month

    Neutrisci Announces Partnership With Rogers Cup Presented by National Bank

    The Rogers Cup, which will be held in Montreal from August 3 – 12, 2018, was identified as an ideal fit for neuenergy® and our primary consumer base of professionals with an active, healthy lifestyle. In keeping with NeutriSci’s mission to bring awareness of neuenergy® to as many people as possible, neuenergy® will be featured as a Bronze Sponsor of the tournament, with a dedicated booth in the spectator’s gallery.   Genie Bouchard and several other neuenergy® Olympic ambassadors will be on-hand to sign autographs and promote neuenergy®. Rogers Cup participants will be able to sample and experience neuenergy® in the retail area on site.

  • GlobeNewswire3 months ago

    NetworkNewsAudio Covers New Patent Application of NeutriSci International Inc. (TXS-V:NU) (OTCQB:NRXCF)

    NEW YORK, March 05, 2018-- via NetworkWire-- NetworkNewsWire, a multifaceted financial news and publishing company for business, today announces the audio version of a press release from NeutriSci International ...

  • Newsfile3 months ago

    Neutrisci Files Patent Application

    Vancouver, British Columbia--(Newsfile Corp. - March 1, 2018) - NeutriSci International Inc. (TSXV: NU) (OTCQB: NRXCF) (FSE: 1N9) (the "Company" or "NeutriSci")  the innovator and pioneer behind neuenergy®, is pleased to announce the filing of a new U.S. provisional patent application (United States Provisional Patent No. 62/628,735; Compositions Comprising Co-crystals of Stilbenoids and Cannabinoids) relating to compositions comprising pterostilbene and other stilbenoids in formulations which improve the dissolution rate and bioavailability of cannabinoid compounds.Cannabinoids ...

  • GlobeNewswire3 months ago

    NeutriSci Files Patent Application

    VANCOUVER, British Columbia, March 01, 2018-- via NetworkWire- NeutriSci International Inc. the innovator and pioneer behind neuenergy ®, is pleased to announce the filing of a new U.S. provisional patent ...

  • GlobeNewswire3 months ago

    NetworkNewsAudio Covers Global Licensing Agreement of Lexaria Bioscience Corp. (CSE:LXX) (OTCQX:LXRP) and NeutriSci International Inc. (TXS-V:NU) (OTCQB:NRXCF)

    NEW YORK, Feb. 28, 2018-- via NetworkWire– NetworkNewsWire, a multifaceted financial news and publishing company for business, today announces the audio version of Lexaria Bioscience Corp.’ s recent press ...

  • Newsfile3 months ago

    Neutrisci and Lexaria Bioscience Enter Global Licensing Agreement

    Vancouver, British Columbia--(Newsfile Corp. - February 26, 2018) - NeutriSci International Inc. (TSXV: NU) (OTCQB: NRXCF) (FSE: 1N9) (the "Company" or "NeutriSci") and Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) ("Lexaria") are pleased to announce that they have revised their joint venture agreement such that NeutriSci now owns 100% of Ambarii Trade Corporation ("Ambarii"), and Lexaria has granted to NeutriSci, an Intellectual Property License and Supply Agreement (the "License Agreement") for the manufacturing and sale of CBD ...

  • GlobeNewswire3 months ago

    NeutriSci and Lexaria Bioscience Enter Global Licensing Agreement

    VANCOUVER, British Columbia, Feb. 26, 2018-- NeutriSci International Inc. and Lexaria Bioscience Corp. are pleased to announce that they have revised their joint venture agreement such that NeutriSci now ...

  • ACCESSWIRE3 months ago

    Lexaria and Neutrisci Enter Global Licensing Agreement

    KELOWNA, BRITISH COLUMBIA / ACCESSWIRE / February 26, 2018 / Lexaria Bioscience Corp. (OTCQX: LXRP) (CSE: LXX) (the "Company" or "Lexaria") a drug delivery platform innovator, announces ...

  • GlobeNewswire3 months ago

    NeutriSci Named to the 2018 TSX Venture 50®

    VANCOUVER, B.C., Feb. 22, 2018-- NeutriSci International Inc. is pleased to announce it has been named to the 2018 TSX Venture 50 ®, an annual ranking of top-performing companies on the TSX Venture Exchange ...

  • Marketwired4 months ago

    NeutriSci Announces Major Sponsorship With Tennis Star Genie Bouchard

    NeutriSci International Inc. , the innovator and pioneer behind neuenergy®, is pleased to announce a one-year sponsorship deal with Canadian and International tennis...

  • Newsfile4 months ago

    Neutrisci Announces a Major R&D MOU with Scientus Pharma to Develop a Medical Cannabinoid Retail Product

    Vancouver, British Columbia--(Newsfile Corp. - January 8, 2018) - NeutriSci International Inc. (TSXV: NU) (OTCQB: NRXCF) (FSE: 1N9) (the "Company" or "NeutriSci"), the innovator and pioneer behind neuenergy®, is pleased to announce it has entered into a major R&D Memorandum of Understanding with Scientus Pharma Inc. ("Scientus Pharma"). Under the terms of the MOU, both companies have agreed to share their technologies to develop, test, produce, and distribute a medical cannabinoid product for existing ...

  • Marketwired7 months ago

    NeutriSci Announces Pending Approval From Japanese Government for Distribution of CBD Products Through Naturally Splendid

    NeutriSci International Inc. , the innovator and pioneer behind neuenergy®, is pleased to announce that its partner in Japan and South Korea for Ambarii Corporation...